Bioventus’ Nexus BoneScalpel Access handpiece was cleared by the FDA.
The handpiece is designed for bone removal during minimally invasive surgery and to provide maximum visualization, according to a Dec. 20 news release. BoneScalpel Access is powered by the company’s ultrasonic surgical aspirator system, which has been commercialized in the U.S., Canada, Europe and Australia.
Bioventus’ BoneScalpel Access is expected to launch in 2022.
Ten thousand patients have been treated with Augmedics’ Xvision augmented reality spine system, the company said April 22. The milestone…
The highest-paid CFO of orthopedic medtech companies in the U.S. saw more than $12 million per year in total compensation…
Spinal device company Alphatec has commercially launched its Prone TransPsoas corpectomy system. The launch marks the expansion of Alphatec’s deformity…
Comments are closed.